- advertisement -

UBC Type 1 diabetes drug trial seeks to end injections

Discussion in 'Research' started by Parody, Apr 22, 2015.

  1. Parody

    Parody Approved members

    Apr 13, 2011
  2. rgcainmd

    rgcainmd Approved members

    Feb 6, 2014
    I don't know whether I'd prefer using ongoing monoclonal antibody therapy in place of insulin in my child with T1D. The list of potential side effects is enough to make me turn heel and run in the opposite direction. Granted, taking too much insulin will result in death, but one would need to take a significant overdose. Whereas "therapeutic" doses of monoclonal Abs can do some pretty nasty things (google "side effects of monoclonal antibody treatment".)

    Additionally, sounds like ustekinumab would perhaps only be useful in slowing the autoimmune destruction of beta cells within a relatively limited time frame after initial diagnosis. Potentially good news for brand-new Type 1s, but for my CWD, not so much...

Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice